Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15413098 | 0.83 | ATM (0.31) | — | |
| SCHEMBL28304501 | 0.77 | DRD2 (0.37) | DRD2DRD1ALDH1A1MAPTNFKB1 | |
| SCHEMBL14525559 | 0.71 | DRD2 (0.36) | DRD2DRD1ALDH1A1MAPTNFKB1 | |
| SCHEMBL26178860 | 0.71 | SIGMAR1 (0.42) | DRD2DRD1ALDH1A1MAPTNFKB1 | |
| SCHEMBL12305071 | 0.71 | MAPT (0.59) | DRD2DRD1ALDH1A1MAPTNFKB1 | |
| SCHEMBL12924515 | 0.68 | CYP3A4 (0.46) | DRD2DRD1ALDH1A1MAPTKDM4E | |
| SCHEMBL12966288 | 0.66 | RIPK1 (0.33) | ALDH1A1 | |
| SCHEMBL13218790 | 0.66 | ALDH1A1 (0.36) | DRD2DRD1ALDH1A1MAPTNFKB1 | |
| SCHEMBL8912019 | 0.66 | AHR (0.38) | DRD2ALDH1A1KDM4E | |
| SCHEMBL11985163 | 0.64 | ALDH1A1 (0.34) | DRD2DRD1ALDH1A1MAPTNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9394221-B2 | Method for manufacturing benzenetetracarboxylic acid | JX NIPPON OIL & ENERGY COMPANY (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20140018569-A1 | METHOD FOR MANUFACTURING BENZENETETRACARBOXYLIC ACID | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2014-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018569-A1 | METHOD FOR MANUFACTURING BENZENETETRACARBOXYLIC ACID | HAAO, HAO2, HPD | DRD2 3402/4885DRD1 3009/4885ALDH1A1 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.